Testing whether focused radiation can be left out after surgery for cancer that spread to the brain
Official title: OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study looks at skipping the usual radiation after brain surgery in people who take cancer medicine that works inside the brain.
Read our full plain-language summary
What the trial team says
To remove a brain tumor, patients usually receive radiation to lower the chance that the cancer will come back in the spot where the tumor was removed.
Key facts
- Registry number
- NCT07655583
- Conditions studied
- Brain Metastasis, Stereotactic Radiosurgery, Resection, Systemic Therapy
Where it is running
This trial lists 1 site.
-
Texas
- MD Anderson Cancer Center (Houston)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.